ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
7 announcements with these filters
Quest Laboratories Limited has scheduled its 28th Annual General Meeting for September 30, 2026, to transact agenda items including financial statements and director appointments.
Quest Laboratories entered a strategic growth and investment facilitation agreement with Niraga Capitals and a consortium. The partnership aims to scale operations and prepare for Mainboard listing.
Quest Laboratories will change its financial result disclosure frequency from quarterly to half-yearly. This change is effective from the 2026-27 financial year.
Quest Laboratories Limited filed its SDD Compliance Certificate for FY2026. The certificate confirms adherence to SEBI Insider Trading regulations regarding Structured Digital Database maintenance.
Quest Laboratories Ltd reported revenue from operations of ₹32.4 Cr (-30.3% YoY) and net profit of ₹2.9 Cr (+52.6% YoY) for Q4 FY26.
Quest Laboratories Limited reported audited standalone net profit of ₹15.02 Crore for FY2026. The board also approved internal, secretarial, and cost auditor appointments.
Quest Laboratories Limited scheduled a May 29 board meeting to consider audited annual results. The trading window remains closed until June 1, 2026.